Monday, October 27, 2014

Merck Revenue Sags 4% in Third Quarter

The pharmaceutical company’s earnings beat expectations, however, helped by sales of the diabetes drug Januvia and revenue in emerging markets.


via NYT > Business Day http://ift.tt/1oQjVkL








via WordPress http://ift.tt/1rMccjo

No comments:

Post a Comment